Pathobiomes in Gut of Critically Ill Patients

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 19, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Pseudomonas Aeruginosa
Interventions
OTHER

P. aeruginosa using in vitro and in vivo assays

This trial will entail collecting and screening stool samples obtained from critically ill patients for their virulence inducing capabilities on laboratory strains of P. aeruginosa using in vitro and in vivo assays. The investigators also plan to isolate strains of intestinal P. aeruginosa from stool samples to determine the prevalence of intestinal P. aeruginosa in a population of critically ill patients.

Trial Locations (1)

60637

RECRUITING

The University of Chicago, Hyde Park

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

University of Chicago

OTHER